Baxter International (BAX)
Baxter International Revenues: 3.388B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BAX Revenues Rankings
| Overall | 93rd percentile | 293 of 4425 |
| Sector | 95th percentile | 21 of 470 in Healthcare |
| Industry | 98th percentile | 1 of 67 in Medical Instruments & Supplies |
BAX Revenues Range, Past 5 Years
| Minimum | 2.75B | Sep 2007 |
| Maximum | 3.594B | Dec 2011 |
| Average | 3.181B |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these BAX related companies
BAX News
Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes
May 25, 7:03AM Street Insider
May 25, 7:03AM Street Insider
Baxter International, Inc. (BAX) Declares $0.335 Quarterly Dividend; 2.4% Yield
May 07, 4:39PM Street Insider
May 07, 4:39PM Street Insider
Baxter to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
May 02, 4:15PM Business Wire
May 02, 4:15PM Business Wire
Raymond James Starts MedTech Sector: CFN, COO, COV at Strong Buy, SLTM, ISRG, BAX at Outperform, BDX at Underperform
Apr 25, 10:00AM Street Insider
Apr 25, 10:00AM Street Insider
Baxter to Present at Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference
Apr 24, 4:15PM Business Wire
Apr 24, 4:15PM Business Wire
News related to $BAX, currently -1.9% since open: 'Baxter International 1Q profit rises 3 percent' http://stks.co/3Pxa
about 38 days ago by TradeBot
about 38 days ago by TradeBot
Listen to $BAX Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3PZ3
about 38 days ago by earningscast
about 38 days ago by earningscast
FDA request for data could delay HYQ approval by a year or more. $HALO $BAX http://stks.co/3Mgq
about 41 days ago by abubnic
about 41 days ago by abubnic
UPDATE: FDA Seeks Added Info On $BAX, $HALO HyQ Therapy. http://stks.co/3Mgh
about 41 days ago by abubnic
about 41 days ago by abubnic
Baxter $BAX, Halozyme $HALO Announce FDA Request for More Info on HyQ Biologics Application
about 42 days ago by Street_Insider
about 42 days ago by Street_Insider
Yesterday we entered an Apr'20 $BAX 57.50/55 bull put spread for 0.35.Seasonal technical data this stock is strong from Apr1 to Apr opt exp
about 47 days ago by TheOxenGroupdotcom
about 47 days ago by TheOxenGroupdotcom
$BAX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DDv
about 54 days ago by MarketBrief
about 54 days ago by MarketBrief
$BAX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C5K
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
$BAX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Amf
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BAX | 51.99 | -0.26 | -0.50% | 28.92B |
| BASI | 1.11 | -0.06 | -4.72% | 7.737M |
| BAS | 11.84 | +0.34 | +2.96% | 504.74M |
| BAP | 120.46 | +0.13 | +0.11% | 9.608B |
| BANR | 19.28 | -0.12 | -0.62% | 344.73M |
| BANF | 37.71 | -0.29 | -0.76% | 570.93M |
| BAMM | 3.24 | +0.02 | +0.62% | 51.22M |
| AVT | 30.55 | -0.11 | -0.36% | 4.431B |
| AVP | 16.59 | -0.13 | -0.78% | 7.149B |
| AVNW | 2.46 | -0.05 | -1.99% | 150.87M |
